今回は「小児注意欠如多動性障害（attention deficit-hyperactivity disorder : ADHD)に対するyoga（ヨガ）の有効性について」の論文のご紹介です。


Indian J Psychiatry. 2013 Jul;55(Suppl 3):S379-84. doi: 10.4103/0019-5545.116317.
Feasibility and efficacy of yoga as an add-on intervention in attention deficit-hyperactivity disorder: An exploratory study.

Hariprasad VR1, Arasappa R, Varambally S, Srinath S, Gangadhar BN.


Abstract
CONTEXT:
Attention deficit-hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders. Stimulant medication is frequently used in management, with significant adverse effects. There is a growing interest in complementary treatments like yoga.
AIMS:
To study the effects of yoga as a complementary therapy in children with moderate to severe ADHD.
SETTINGS AND DESIGN:
The study was performed on children (consent was taken from parents) admitted in a child psychiatry unit using an open-label exploratory study.
MATERIALS AND METHODS:
Children between 5 and 16 years of age diagnosed with ADHD and co-operative for yoga were included. Subjects with other serious psychiatric and medical illnesses were excluded. The participants were given yoga training daily during their in-patient stay. They were rated on Conners' abbreviated rating scale - (CARS), ADHD-rating scale-IV (ADHD - RS IV) and clinical global impression (CGI)-Severity, at the beginning of study, at discharge and subsequently at the end of 1(st), 2(nd) and 3(rd) month by a research associate not involved in yoga instruction. Paired t-test was employed to compare the means of scores between baseline and follow-ups.
RESULTS:
A total of 9 children (8 males, 1 female) were recruited into the study. All, but one were on medications. An average of 8 yoga training sessions was given to subjects. They were able to learn yoga reasonably well. There was a significant improvement in the ADHD symptoms as assessed on CARS (P-0.014), ADHD-RS IV (P=0.021) and CGI- S scales (P=0.004) at the time of discharge.


小児ＡＤＨＤに対するヨガセラピーの有効性についての論文です。ＡＤＨＤ症状の評価はＣＡＲＳで行っており、有意に改善しています。
オープンラベル試験なのでエビデンスレベルは高くないですが、データを蓄積していくことが重要です。内服以外での治療的アプローチは多い方が選択肢は広がります。他の治療についても調べてアップしていきます。


記事作成：加藤晃司（医療法人永朋会）
　　　　　専門：児童精神科（日本児童青年期精神医学会認定医、子どものこころ専門医）